OpenVSafe by OpenVAERS
Search V-safe

CEZ-70631-54695

2 vaccinations 5 coded responses 11 check-ins 5 free-text entries 2 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
506 / IA
Registered
2020-12-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
1242280 (opens in a new window) high 10 / 11 -3 1 of 4 VAERS symptoms same dose (2) IA matches 2021-01-13 / 2021-04-08 / 2021-04-22
received the same day as the last call
 case 526139

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2020-12-22
    Registered in v-safe
  2. 2020-12-22
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-29
    Health check-in — day 7, dose 1
    Feeling: Good · Site: Pain, Redness, Swelling · None
    Adult check-in
  4. 2021-01-06
    Survey response — day 14, dose 1
    MedDRA: Injection site erythema, Injection site pruritus, Injection site swelling — Feeling: Fair
    Free text: Increasing Itching, redness, and swelling at injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-13
    Dose 2 — Pfizer-BioNTech
  6. 2021-01-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Heart rate increased — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activities
    Free text: Rapid heartbeat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-01-14
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  8. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness
    Adult check-in
  9. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-01-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-02-05
    Survey response — day 21, dose 2
    MedDRA: Injection site discolouration — Feeling: Good
    Free text: Discoloration of injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-02-19
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-04-15
    Survey response — 3 months, dose 2
    MedDRA: Haemorrhage, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Pregnancy blood hemorrhage
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-04-15
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  15. 2021-04-16
  16. 2021-04-22
    Call successful
    Completed over the phone
  17. 2021-07-16
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2022-01-15
    Survey response — 12 months, dose 2
    MedDRA: Delivery, Nasopharyngitis — Feeling: Fair
    Free text: Cold type symptoms. Had a baby.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-22Pfizer-BioNTech
22021-01-13Pfizer-BioNTech

Call center

2 call center cases

1 successful · 1 priority 2/3 (triaged and no follow up)

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 1 — day 14, dose 1

2021-01-06

Symptoms: Increasing Itching, redness, and swelling at injection site

Release 1 — days 1–6 daily, dose 2

2021-01-14

Systemic reaction (other): Rapid heartbeat

Release 3 — day 21, dose 2

2021-02-05

Symptoms: Discoloration of injection site

Release 7 — 3 months, dose 2

2021-04-15

Symptoms: Pregnancy blood hemorrhage

Release 10 — 12 months, dose 2

2022-01-15

Symptoms: Cold type symptoms. Had a baby.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDelivery · · ✓
SDHaemorrhage ✓ ✓ ✓
SDInjection site discolouration ✓ ✓ ✓
SDInjection site erythema ✓ ✓ ✓
SDInjection site pruritus ✓ ✓ ✓
SDInjection site swelling ✓ ✓ ✓
SDNasopharyngitis · · ✓
SDPregnancy ✓ ✓ ✓
SROHeart rate increased ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…